Search

everythinglearnresearchcommunity

for

Search:↓

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

FPHL is common in women, influenced by genetics and hormones, and can be treated with medications, laser therapy, or hair transplantation.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Female pattern hair loss treatments vary in effectiveness and may have side effects.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Obesity and negative body image harm mental health and quality of life in women with PCOS.

EF and PXE not closely related.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

Spironolactone might cause painful intercourse and decreased sexual arousal in women.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

New treatments for PCOS focus on managing symptoms and improving fertility.

The document concludes that awareness and understanding of hidradenitis suppurativa are increasing, but effective treatments are still needed.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

Testosterone therapy can help women with androgen deficiency by improving energy, sex drive, and bone health with few side effects.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Dr. Vera H. Price's 1979 work emphasizes the importance of accurate diagnosis and personalized treatment for hair loss.

AMH levels are higher in women with PCOS and can indicate the number of small follicles in their ovaries.

PCOS is linked to changes in vaginal bacteria, with fewer good bacteria and more harmful ones.

Women with PCOS may have a higher risk of respiratory and ear infections due to slower nasal mucociliary clearance.

The document concludes that a thorough history, physical exam, and specific tests are crucial for diagnosing and managing hair loss effectively.

Hormones are crucial for regulating body functions and imbalances can lead to health issues.

N-acetyl-cysteine shows promise in treating various diseases and may improve skin and hair conditions, but more research is needed on dosages and long-term effects.

A postmenopausal woman's masculine symptoms improved after surgery for a hormone-producing ovarian tumor.

Androgens, like DHT, affect hair growth and treatments like finasteride may help.